Cart summary

You have no items in your shopping cart.

Lirentelimab Antibody

SKU: orb1980575

Description

Lirentelimab (AK002) is a humanized monoclonal antibody targeting Siglec-8. It triggers apoptosis in activated eosinophils and inhibits mast cell activation, making it a research tool for studying conditions like systemic mastocytosis and allergic conjunctivitis. Its mechanisms have been investigated in both in vitro assays and in vivo preclinical models.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number2283348-97-8
MW144.55 kDa
Purity97.7% (SDS-PAGE); 99.7% (SEC-HPLC)
TargetApoptosis

Bioactivity

Target IC50
SIGLEC8:464 pM (affinity)
In Vivo
Lirentelimab significantly inhibited IgE-mediated mast cell activation after a single intravenous injection at a dose of 100 μg in a mouse model of systemic allergic reaction.
In Vitro
The antigen-binding fragment of Lirentelimab binds with an affinity of 464 pM to the extracellular structural domain of recombinant SIGLEC8. Lirentelimab exhibits a high affinity for in vitro-expressed SIGLEC8 as well as SIGLEC8 expressed on eosinophils and via the Fc region on NK cells. At a concentration of 1 µg/mL, Lirentelimab selectively binds to eosinophils in human peripheral blood as well as eosinophils and mast cells in human lung tissue. In addition, Lirentelimab induced apoptosis in IL-5-activated eosinophils when acted at concentrations ranging from 0.0001 to 100 μg/mL for 30 minutes. In peripheral blood leukocyte samples from healthy donors, Lirentelimab had a half-maximal effect concentration of 1.9 ng/mL on eosinophils and elicited an antibody-dependent cytotoxic response.Lirentelimab also reduced the number of eosinophils in isolated human tissues.

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

AK 002, AK002, Anti-Siglec-8 Reference Antibody, Antolimab, Apoptosis

Similar Products

  • Siglec-8 Reference Antibody (lirentelimab) [orb1817763]

    FC,  Kinetics

    Human, Mouse

    Monoclonal

    Unconjugated

    100 μg
  • Lirentelimab Human Monoclonal Antibody [orb2977043]

    ELISA,  FA,  FACS,  In vivo

    Human

    Human Humanized

    Monoclonal

    Unconjugated

    1 mg, 100 μg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Lirentelimab Antibody (orb1980575)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
¥ 3,120.00
5 mg
¥ 7,280.00
10 mg
¥ 11,310.00
25 mg
¥ 16,510.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry